These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

213 related articles for article (PubMed ID: 38625978)

  • 1. SLC2A3 promotes tumor progression through lactic acid-promoted TGF-β signaling pathway in oral squamous cell carcinoma.
    Jiang W; Xu S; Li P
    PLoS One; 2024; 19(4):e0301724. PubMed ID: 38625978
    [TBL] [Abstract][Full Text] [Related]  

  • 2. MiR-455-5p suppresses PDZK1IP1 to promote the motility of oral squamous cell carcinoma and accelerate clinical cancer invasion by regulating partial epithelial-to-mesenchymal transition.
    Hsiao SY; Weng SM; Hsiao JR; Wu YY; Wu JE; Tung CH; Shen WL; Sun SF; Huang WT; Lin CY; Chen SH; Hong TM; Chen YL; Chang JY
    J Exp Clin Cancer Res; 2023 Feb; 42(1):40. PubMed ID: 36737832
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Immunity-related long noncoding RNA WDFY3-AS2 inhibited cell proliferation and metastasis through Wnt/β-catenin signaling in oral squamous cell carcinoma.
    Lin X; Ding JM; Zheng XZ; Chen JG
    Arch Oral Biol; 2023 Mar; 147():105625. PubMed ID: 36657277
    [TBL] [Abstract][Full Text] [Related]  

  • 4. miR-450b promotes cell migration and invasion by inhibiting SERPINB2 in oral squamous cell carcinoma.
    Wang X; Nie X; Xu G; Gao J; Wang B; Yang J; Song G
    Oral Dis; 2024 Mar; 30(2):376-389. PubMed ID: 36251494
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Knockdown of lncRNA IGF2BP2-AS1 inhibits proliferation and migration of oral squamous cell carcinoma cells via the Wnt/β-catenin pathway.
    Tong S; Wang X; Guo X; Lu Z
    J Oral Pathol Med; 2022 Mar; 51(3):272-280. PubMed ID: 34637162
    [TBL] [Abstract][Full Text] [Related]  

  • 6. CircLDLRAD3 inhibits Oral squamous cell carcinoma progression by regulating miR-558/Smad4/TGF-β.
    Zhang X; Guo GY; Liu RY; Wu T; Wang ZH; Zhang ZT
    J Cell Mol Med; 2023 Nov; 27(21):3271-3285. PubMed ID: 37563869
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Loss of RUNX3 expression inhibits bone invasion of oral squamous cell carcinoma.
    Park J; Kim HJ; Kim KR; Lee SK; Kim H; Park KK; Chung WY
    Oncotarget; 2017 Feb; 8(6):9079-9092. PubMed ID: 28030842
    [TBL] [Abstract][Full Text] [Related]  

  • 8. CircPVT1 facilitates the progression of oral squamous cell carcinoma by regulating miR-143-3p/SLC7A11 axis through MAPK signaling pathway.
    Wang S; Li W; Yang L; Yuan J; Wang L; Li N; Zhao H
    Funct Integr Genomics; 2022 Oct; 22(5):891-903. PubMed ID: 35624316
    [TBL] [Abstract][Full Text] [Related]  

  • 9. MicroRNA-495 confers inhibitory effects on cancer stem cells in oral squamous cell carcinoma through the HOXC6-mediated TGF-β signaling pathway.
    You X; Zhou Z; Chen W; Wei X; Zhou H; Luo W
    Stem Cell Res Ther; 2020 Mar; 11(1):117. PubMed ID: 32171324
    [TBL] [Abstract][Full Text] [Related]  

  • 10. CircZDBF2 up-regulates RNF145 by ceRNA model and recruits CEBPB to accelerate oral squamous cell carcinoma progression via NFκB signaling pathway.
    Rong L; Chen B; Liu K; Liu B; He X; Liu J; Li J; He M; Zhu L; Liu K; Shi X; Shuai Y; Jin L
    J Transl Med; 2022 Apr; 20(1):148. PubMed ID: 35365168
    [TBL] [Abstract][Full Text] [Related]  

  • 11. TGF-βRII/EP300/SMAD4 cascade signaling pathway promotes invasion and glycolysis in oral squamous cell carcinoma.
    Zhang D; Peng Y; Lin G; Xiao Q; Liu H; Nan X; Han J; Zhao R; Wang Y; Liu J; Liu Y
    J Oral Pathol Med; 2023 Jul; 52(6):483-492. PubMed ID: 36916236
    [TBL] [Abstract][Full Text] [Related]  

  • 12. RELA promotes the progression of oral squamous cell carcinoma via TFAP2A-Wnt/β-catenin signaling.
    Yang K; Zhao J; Liu S; Man S
    Mol Carcinog; 2023 May; 62(5):641-651. PubMed ID: 36789977
    [TBL] [Abstract][Full Text] [Related]  

  • 13. MicroRNA-191 regulates oral squamous cell carcinoma cells growth by targeting PLCD1 via the Wnt/β-catenin signaling pathway.
    Wang Z; Guan W; Ma Y; Zhou X; Song G; Wei J; Wang C
    BMC Cancer; 2023 Jul; 23(1):668. PubMed ID: 37460940
    [TBL] [Abstract][Full Text] [Related]  

  • 14. BST2 regulated by the transcription factor STAT1 can promote metastasis, invasion and proliferation of oral squamous cell carcinoma via the AKT/ERK1/2 signaling pathway.
    Shan F; Shen S; Wang X; Chen G
    Int J Oncol; 2023 Apr; 62(4):. PubMed ID: 36929425
    [TBL] [Abstract][Full Text] [Related]  

  • 15. LncOCMRL1 promotes oral squamous cell carcinoma growth and metastasis via the RRM2/EMT pathway.
    Lu N; Jiang Q; Xu T; Gao Q; Wang Y; Huang Z; Huang Z; Xu X
    J Exp Clin Cancer Res; 2024 Sep; 43(1):267. PubMed ID: 39343925
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Role of miR-218-GREM1 axis in epithelial-mesenchymal transition of oral squamous cell carcinoma: An in vivo and vitro study based on microarray data.
    Wang Y; Jiang Y; Chen L
    J Cell Mol Med; 2020 Dec; 24(23):13824-13836. PubMed ID: 33107676
    [TBL] [Abstract][Full Text] [Related]  

  • 17. FERMT1 knockdown inhibits oral squamous cell carcinoma cell epithelial-mesenchymal transition by inactivating the PI3K/AKT signaling pathway.
    Wang X; Chen Q
    BMC Oral Health; 2021 Nov; 21(1):598. PubMed ID: 34814915
    [TBL] [Abstract][Full Text] [Related]  

  • 18. CLSPN actives Wnt/β-catenin signaling to facilitate glycolysis and cell proliferation in oral squamous cell carcinoma.
    Hou Z; Wu C; Tang J; Liu S; Li L
    Exp Cell Res; 2024 Feb; 435(2):113935. PubMed ID: 38237848
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Glycolysis-Related Gene Analyses Indicate That DEPDC1 Promotes the Malignant Progression of Oral Squamous Cell Carcinoma via the WNT/β-Catenin Signaling Pathway.
    Huang G; Chen S; Washio J; Paka Lubamba G; Takahashi N; Li C
    Int J Mol Sci; 2023 Jan; 24(3):. PubMed ID: 36768316
    [TBL] [Abstract][Full Text] [Related]  

  • 20. TAB2 Promotes the Biological Functions of Head and Neck Squamous Cell Carcinoma Cells via EMT and PI3K Pathway.
    Liu H; Zhang H; Fan H; Tang S; Weng J
    Dis Markers; 2022; 2022():1217918. PubMed ID: 35978886
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.